Jul 8, 2026
Do Early-Stage Founders Actually Want to Win?
The Mindset Gap Between Wanting to Succeed and Planning to. After 3 days at MedTech Innovator Radar Forum, I caught...
Read More
Articles, talks, and frameworks on FDA strategy, clinical development, fundraising, and commercialization — from the team behind 200+ medical innovations brought to market. Built for MedTech and Biotech founders who need precision, not platitudes.
If you’re building a medical device or health technology company for the first time, this one’s for you. This white paper lays out what the regulatory and FDA process actually looks like for early-stage founders, and when you should start the process.
Inside, you’ll find:
Watch and listen – keynotes, conference sessions, and podcast conversations on regulatory strategy, clinical evidence, and commercialization.
Bring your device, your current status, and your assumptions to a focused 60-minute strategy session. You’ll leave knowing whether your classification logic holds, what FDA will ask in your pre-sub or market submission, and whether a study is likely — clarity before you spend against the wrong pathway.
Practical insights on FDA strategy, clinical development, and capital-efficient commercialization – written for founders, not for compliance departments. No noise, unsubscribe anytime.
If you’re serious about getting to market, we’ll help you chart the course – tailored to your product, pathway, and budget.
